No fanfare as Novartis's Jimenez succeeds Viehbacher at EFPIA
This article was originally published in SRA
Executive Summary
Novartis CEO Joe Jimenez has been quietly ushered in to replace Chris Viehbacher as president of EFPIA, the body representing the R&D-based pharmaceutical industry in Europe.